A detailed history of Northern Trust Corp transactions in Rx Sight, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 377,298 shares of RXST stock, worth $17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
377,298
Previous 312,498 20.74%
Holding current value
$17 Million
Previous $18.8 Million 0.82%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.78 - $57.04 $2.64 Million - $3.7 Million
64,800 Added 20.74%
377,298 $18.6 Million
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $569,090 - $725,641
-11,287 Reduced 3.49%
312,498 $18.8 Million
Q1 2024

May 14, 2024

SELL
$35.51 - $57.92 $203,649 - $332,171
-5,735 Reduced 1.74%
323,785 $16.7 Million
Q4 2023

Feb 13, 2024

BUY
$20.91 - $40.9 $1.89 Million - $3.69 Million
90,326 Added 37.76%
329,520 $13.3 Million
Q3 2023

Nov 13, 2023

BUY
$27.05 - $33.37 $449,300 - $554,275
16,610 Added 7.46%
239,194 $6.67 Million
Q2 2023

Aug 11, 2023

BUY
$16.37 - $28.9 $622,174 - $1.1 Million
38,007 Added 20.59%
222,584 $6.41 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $362,580 - $480,750
28,822 Added 18.5%
184,577 $3.08 Million
Q4 2022

Feb 13, 2023

BUY
$9.93 - $14.2 $53,065 - $75,884
5,344 Added 3.55%
155,755 $1.97 Million
Q3 2022

Nov 14, 2022

BUY
$11.19 - $15.85 $14,390 - $20,383
1,286 Added 0.86%
150,411 $1.81 Million
Q2 2022

Aug 12, 2022

BUY
$10.61 - $16.66 $163,033 - $255,997
15,366 Added 11.49%
149,125 $2.1 Million
Q1 2022

May 13, 2022

BUY
$8.97 - $14.03 $527,570 - $825,174
58,815 Added 78.48%
133,759 $1.66 Million
Q4 2021

Feb 08, 2022

BUY
$9.52 - $13.81 $39,784 - $57,711
4,179 Added 5.91%
74,944 $843,000
Q3 2021

Nov 15, 2021

BUY
$11.85 - $17.32 $838,565 - $1.23 Million
70,765 New
70,765 $897,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.25B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.